Wang, R., Xu, Y., Niu, X., Fang, Y., Guo, D., Chen, J., . . . Zhang, M. (2021). MiR-22 Inhibition Alleviates Cardiac Dysfunction in Doxorubicin-Induced Cardiomyopathy by Targeting the sirt1/PGC-1α Pathway. Front Physiol.
Chicago ZitierstilWang, Runze, et al. "MiR-22 Inhibition Alleviates Cardiac Dysfunction in Doxorubicin-Induced Cardiomyopathy By Targeting the Sirt1/PGC-1α Pathway." Front Physiol 2021.
MLA ZitierstilWang, Runze, et al. "MiR-22 Inhibition Alleviates Cardiac Dysfunction in Doxorubicin-Induced Cardiomyopathy By Targeting the Sirt1/PGC-1α Pathway." Front Physiol 2021.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.